Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B:: Implications for immunotherapy

被引:357
作者
Webster, GJM
Reignat, S
Brown, D
Ogg, GS
Jones, L
Seneviratne, SL
Williams, R
Dusheiko, G
Bertoletti, A
机构
[1] UCL, Inst Hepatol, London WC1E 6HX, England
[2] INMI L Spallanzani, I-00149 Rome, Italy
[3] John Radcliffe Hosp, Inst Mol Med, Mol Immunol Grp, Oxford OX3 9DU, England
[4] Royal Free Hosp, Ctr Hepatol, London NW3 2QG, England
基金
英国医学研究理事会;
关键词
D O I
10.1128/JVI.78.11.5707-5719.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学]; 100705 [微生物与生化药学];
摘要
The cytotoxic T-cell response in chronic hepatitis B virus (HBV) infection has been described as weak and mono- or oligospecific in comparison to the more robust virus-specific T-cell response present in resolved infection. However, chronic hepatitis B is a heterogeneous disease with markedly variable levels of virus replication and liver disease activity. Here we analyzed (both directly ex vivo and after in vitro stimulation) the HBV-specific CD8 T-cell responses against structural and nonstructural HBV proteins longitudinally in patients with different patterns of chronic infections. We found that the profiles of virus-specific CD8(+)-T-cell responses during chronic infections are highly heterogeneous and influenced more by the level of HBV replication than by the activity of liver disease. An HBV DNA load of <10(7) copies/ml appears to be the threshold below which circulating multispecific HBV-specific CD8(+) T cells are consistently detected. Furthermore, CD8(+) T cells with different specificities are differentially regulated during chronic infections. HBV core-specific CD8(+) T cells are associated with viral control, while CD8(+) T cells specific for envelope and polymerase epitopes can occasionally be found in the setting of high levels (>10(7) copies) of HBV replication. These findings have implications for the design of immunotherapy for chronic HBV infections.
引用
收藏
页码:5707 / 5719
页数:13
相关论文
共 43 条
[1]
Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL [J].
AlexanderMiller, MA ;
Leggatt, GR ;
Sarin, A ;
Berzofsky, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :485-492
[2]
CYTOTOXIC T-LYMPHOCYTE RESPONSE TO A WILD-TYPE HEPATITIS-B VIRUS EPITOPE IN PATIENTS CHRONICALLY INFECTED BY VARIANT VIRUSES CARRYING SUBSTITUTIONS WITHIN THE EPITOPE [J].
BERTOLETTI, A ;
COSTANZO, A ;
CHISARI, FV ;
LEVRERO, M ;
ARTINI, M ;
SETTE, A ;
PENNA, A ;
GIUBERTI, T ;
FIACCADORI, F ;
FERRARI, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (03) :933-943
[3]
Translation of immunological knowledge into better treatments of chronic hepatitis B [J].
Bertoletti, A ;
Naoumov, NV .
JOURNAL OF HEPATOLOGY, 2003, 39 (01) :115-124
[4]
Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis [J].
Bertoni, R ;
Sidney, J ;
Fowler, P ;
Chesnut, RW ;
Chisari, FV ;
Sette, A .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (03) :503-513
[5]
Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination:: Stimulation of the in vitro antibody response by interferon gamma [J].
Böcher, WO ;
Herzog-Hauff, S ;
Schlaak, J ;
zum Büschenfelde, KHM ;
Löhr, HF .
HEPATOLOGY, 1999, 29 (01) :238-244
[6]
Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy [J].
Boni, C ;
Penna, A ;
Ogg, GS ;
Bertoletti, A ;
Pilli, M ;
Cavallo, C ;
Cavalli, A ;
Urbani, S ;
Boehme, R ;
Panebianco, R ;
Fiaccadori, F ;
Ferrari, C .
HEPATOLOGY, 2001, 33 (04) :963-971
[7]
T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens [J].
Brehm, MA ;
Pinto, AK ;
Daniels, KA ;
Schneck, JP ;
Welsh, RM ;
Selin, LK .
NATURE IMMUNOLOGY, 2002, 3 (07) :627-634
[8]
Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses [J].
Chen, WS ;
Antón, LC ;
Bennink, JR ;
Yewdell, JW .
IMMUNITY, 2000, 12 (01) :83-93
[9]
Cytotoxic T cells and viral hepatitis [J].
Chisari, FV .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) :1472-1477
[10]
FERRARI C, 1990, J IMMUNOL, V145, P3442